CWD [CWD] vs Cyient DLM [CYIENTDLM] Detailed Stock Comparison

CWD

Cyient DLM
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: CWD wins in 7 metrics, Cyient DLM wins in 9 metrics, with 1 ties. Cyient DLM appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | CWD | Cyient DLM | Better |
---|---|---|---|
P/E Ratio (TTM) | 256.36 | 53.45 | Cyient DLM |
Price-to-Book Ratio | 10.89 | 3.65 | Cyient DLM |
Debt-to-Equity Ratio | 14.80 | 31.73 | CWD |
PEG Ratio | N/A | -1.79 | N/A |
EV/EBITDA | 122.68 | 26.60 | Cyient DLM |
Profit Margin (TTM) | 7.62% | 4.22% | CWD |
Operating Margin (TTM) | 21.33% | 5.22% | CWD |
EBITDA Margin (TTM) | 21.33% | 5.22% | CWD |
Return on Equity | 5.77% | 7.17% | Cyient DLM |
Return on Assets (TTM) | 4.02% | 4.02% | Tie |
Free Cash Flow (TTM) | $-3.01M | $-1.12B | CWD |
1-Year Return | 119.42% | -38.28% | CWD |
Price-to-Sales Ratio (TTM) | 22.33 | 2.25 | Cyient DLM |
Enterprise Value | $6.17B | $37.17B | Cyient DLM |
EV/Revenue Ratio | 18.75 | 2.41 | Cyient DLM |
Gross Profit Margin (TTM) | N/A | 40.21% | N/A |
Revenue per Share (TTM) | $87 | $194 | Cyient DLM |
Earnings per Share (Diluted) | $6.53 | $8.17 | Cyient DLM |
Beta (Stock Volatility) | -0.62 | -0.30 | CWD |
CWD vs Cyient DLM Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
CWD | -2.00% | 7.85% | 13.16% | 52.48% | 78.21% | 119.30% |
Cyient DLM | 4.51% | 3.05% | -8.06% | -12.84% | 3.49% | -36.27% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
CWD | 119.42% | -12.46% | 871.68% | 871.68% | 871.68% | 871.68% |
Cyient DLM | -38.28% | -14.57% | -14.57% | -14.57% | -14.57% | -14.57% |
News Based Sentiment: CWD vs Cyient DLM
CWD
News based Sentiment: POSITIVE
CWD Ltd. experienced a strong month with a new 52-week high, positive financial results, and significant changes in shareholding. While the PE ratio is high, the overall trend suggests positive momentum and growing investor interest, making it a noteworthy month for the company.
Cyient DLM
News based Sentiment: MIXED
The month presented a mixed bag for Cyient DLM, with positive revenue and operating profit growth offset by a decline in net profit and underperformance compared to its sector. The technical analysis adds to the cautious outlook, making it a moderately significant month for investors.
Performance & Financial Health Analysis: CWD vs Cyient DLM
Metric | CWD | CYIENTDLM |
---|---|---|
Market Information | ||
Market Cap | ₹7.41B | ₹35.81B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 2,320 | 134,408 |
90 Day Avg. Volume | 2,040 | 170,251 |
Last Close | ₹1,715.00 | ₹448.10 |
52 Week Range | ₹760.00 - ₹1,765.30 | ₹378.60 - ₹744.25 |
% from 52W High | -2.85% | -39.79% |
All-Time High | ₹2,425.00 (Oct 31, 2022) | ₹883.80 (Feb 26, 2024) |
% from All-Time High | -29.28% | -49.30% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.71% | 0.08% |
Quarterly Earnings Growth | 0.18% | -0.30% |
Financial Health | ||
Profit Margin (TTM) | 0.08% | 0.04% |
Operating Margin (TTM) | 0.21% | 0.05% |
Return on Equity (TTM) | 0.06% | 0.07% |
Debt to Equity (MRQ) | 14.80 | 31.73 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹153.67 | ₹119.72 |
Cash per Share (MRQ) | ₹71.97 | ₹5.94 |
Operating Cash Flow (TTM) | ₹17.47M | ₹180.85M |
Levered Free Cash Flow (TTM) | ₹-10,122,125 | ₹680.76M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: CWD vs Cyient DLM
Metric | CWD | CYIENTDLM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 256.36 | 53.45 |
Forward P/E | N/A | 26.11 |
PEG Ratio | N/A | -1.79 |
Price to Sales (TTM) | 22.33 | 2.25 |
Price to Book (MRQ) | 10.89 | 3.65 |
Market Capitalization | ||
Market Capitalization | ₹7.41B | ₹35.81B |
Enterprise Value | ₹6.17B | ₹37.17B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 18.75 | 2.41 |
Enterprise to EBITDA | 122.68 | 26.60 |
Risk & Other Metrics | ||
Beta | -0.62 | -0.30 |
Book Value per Share (MRQ) | ₹153.67 | ₹119.72 |
Financial Statements Comparison: CWD vs Cyient DLM
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CWD | CYIENTDLM |
---|---|---|
Revenue/Sales | N/A | ₹2.78B |
Cost of Goods Sold | N/A | ₹1.66B |
Gross Profit | N/A | ₹1.12B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | ₹145.41M |
EBITDA | N/A | ₹292.34M |
Pre-Tax Income | N/A | ₹101.01M |
Income Tax | N/A | ₹26.38M |
Net Income (Profit) | N/A | ₹74.63M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CWD | CYIENTDLM |
---|---|---|
Cash & Equivalents | ₹272.60M | ₹471.17M |
Total Current Assets | ₹679.47M | ₹12.82B |
Total Current Liabilities | ₹218.30M | ₹5.34B |
Long-Term Debt | ₹35.98M | ₹1.95B |
Total Shareholders Equity | ₹583.51M | ₹9.49B |
Retained Earnings | ₹77.24M | ₹2.26B |
Property, Plant & Equipment | ₹39.28M | ₹324.61M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CWD | CYIENTDLM |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | CWD | CYIENTDLM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 2,320 | 134,408 |
Average Daily Volume (90 Day) | 2,040 | 170,251 |
Shares Outstanding | 3.80M | 79.31M |
Float Shares | 1.38M | 37.97M |
% Held by Insiders | 0.75% | 0.61% |
% Held by Institutions | 0.00% | 0.22% |
Dividend Analysis & Yield Comparison: CWD vs Cyient DLM
Metric | CWD | CYIENTDLM |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |